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Abstract 
Background 
Type 1 diabetes is associated with raised inflammation, impaired endothelial progenitor cell 
mobilisation and increased markers of vascular injury. Both acute and chronic exercise is 
known to influence these markers in non-diabetic controls, but limited data exists in Type 1 
diabetes. We assessed inflammation, vascular repair and injury at rest and after exercise in 
physically-fit males with and without Type 1 diabetes. 
Methods 
Ten well-controlled type 1 diabetes (27 ± 2 years; BMI 24 ± 0.7 kg.m
2
; HbA1c 53.3 ± 2.4 
mmol/mol) and nine non-diabetic control males (27 ± 1 years; BMI 23 ± 0.8 kg.m
2
) matched 
for age, BMI and fitness completed 45-min of running. Venous blood samples were collected 
60-min before and 60-min after exercise, and again on the following morning. Blood samples 
were processed for TNF-α using ELISA, and circulating endothelial progenitor cells (cEPCs; 
CD45
dim
CD34
+
VEGFR2
+
) and endothelial cells (cECs; CD45
dim
CD133
-
CD34
+
CD144
+
) 
counts using flow-cytometry. 
Results 
TNF-α concentrations were 4-fold higher at all-time points in Type 1 diabetes, when 
compared with control (P < 0.001). Resting cEPCs were similar between groups; after 
exercise there was a significant increase in controls (P = 0.016), but not in Type 1 diabetes (P 
= 0.202). CEPCs peaked the morning after exercise, with a greater change in controls vs. 
Type 1 diabetes (+139 % vs. 27 %; P = 0.01). CECs did not change with exercise and were 
similar between groups at all points (P > 0.05). Within the Type 1 diabetes group, the delta 
change in cEPCS from rest to the following morning was related to HbA1c (r = -0.65, P = 
0.021) and TNF-α (r = -0.766, P = 0.005). 
Conclusions 
Resting cEPCs and cECs in Type 1 diabetes patients with excellent HbA1c and high physical-
fitness are comparable to healthy controls, despite eliciting 4-fold greater TNF-α. 
Furthermore, Type 1 diabetes patients appear to have a blunted post-exercise cEPCs response 
(vascular repair), whilst a biomarker of vascular injury (cECs) remained comparable to 
healthy controls. 
Keywords 
TNF-α, Endothelial progenitor cells, Circulating endothelial cells 
Background 
Exercise carries many health benefits for people with Type 1 diabetes [1]. Of particular 
importance, regular physical exercise is associated with improvements in an array of 
cardiovascular risk factors such as cardiorespiratory fitness, endothelial function, and blood 
lipid profiles. These benefits are of significance given the raised cardiovascular risk and early 
mortality in these patients [2]. 
Exposure to hyperglycaemia and chronic inflammation ultimately means that individuals with 
Type 1 diabetes demonstrate raised markers of vascular damage, such as circulating 
endothelial cells (cECs; [3]), and endothelial dysfunction [4], in comparison with healthy 
controls [4, 3]. Accompanying this may be a reduction in circulating endothelial progenitor 
cell count (cEPCs; [4, 5]); bone marrow derived cEPCs are highly important for vascular 
repair and protection [5, 6] and are a significant predictor of endothelial function [4, 7] and 
cardiovascular risk [7]. 
A single exercise bout has been shown to acutely raise cEPCs count in both healthy and 
patient populations [8–11]. For example, Rehman et al [8] demonstrated that a single bout of 
cycling exercise significantly raised cEPCs by ~4 fold after exercise, in sedentary over 
weight males. Similar increases in cEPCs after exercise have been demonstrated in healthy, 
physically fit individuals, as well as in sedentary individuals with chronic disease [9]. 
However, data on the acute cEPCs response to exercise within Type 1 diabetes is lacking. 
Regular exercise training is associated with raised resting cEPCs and has a strong anti-
inflammatory effect [12, 13]. Indeed, these benefits are likely integral to the cardio-protective 
role regular exercise provides. With this in mind, and the association of Type 1 diabetes with 
reduced cEPCs and raised inflammation, it is of scientific importance to determine the acute 
cEPCs response to exercise within Type 1 diabetes patients. 
Moreover, how the resting cEPCs, cECs and inflammatory status of physically fit type 1 
diabetes patients compares to matched, non-diabetic controls would also be of interest. 
Physical fitness is a measure that is not considered within the existing literature comparing 
cEPCs (marker of vascular repair), cECs (marker of vascular damage) and inflammation in 
this population [4, 3]. Therefore, the aim of this study was to assess the cEPCs, cECs and 
inflammation at rest and in response to submaximal exercise in physically-fit males with and 
without Type 1 diabetes. 
Methods 
Participants 
Eligibility criteria for type 1 diabetes patients consisted of being aged between 18 and 35 
years, a duration of diabetes > 2 years, and an HbA1c < 8.0 % (64 mmol/mol). In addition, 
patients were required to be free of all diabetes-related complications including impaired 
awareness of hypoglycaemia (assessed via the Clarke method [14]) and not receiving any 
medication other than insulin. Participants in both the Type 1 diabetes and control group had 
to be regularly and consistently undertaking exercise (participating in aerobic based exercise 
for a minimum of 30 min at a time, at least three times per week, for > 12 months). Smokers 
were excluded from both groups. Ten males with type 1 diabetes and nine non-diabetic male 
controls, matched for age, anthropometry, and fitness were recruited for this study (Table 1). 
Patients were treated with a basal-bolus regimen composed of long-acting insulins glargine (n 
= 8) or detemir (n = 2), and rapid-acting insulin aspart. All patients were stable on their 
respective insulin regimen for a minimum of 1 year, and were familiar with carbohydrate 
counting, administering 1.0 ± 0.2 units of insulin aspart (IU) per 10 g of carbohydrate. 
Table 1 Type 1 diabetes and control group participant characteristics mean ± SEM 
 
T1DM CON P value 
Age (years) 27 ± 2 27 ± 1 =0.798 
BMI (kg.m
2
) 24 ± 0.7 23 ± 0.8 =0.243 
VO2max (ml.kg.min
-1
) 51.0 ± 2.1 50.7 ± 1.1 =0.808 
HbA1c (mmol/mol / %) 53.3 ± 2.4 /6.9 ± 0.2 % --- --- 
Diabetes duration (years) 12 ± 2.0 --- --- 
P calculated from independent samples t-test 
BMI Body Mass Index, VO2max aerobic capacity 
Preliminary testing 
Fully informed written consent was obtained from all participants following the study’s 
approval from local National Health Service Research Ethics Committee (13/NE/0016). Type 
1 diabetes participants attended the Newcastle National Institute for Health Research Clinical 
Research Facility exercise laboratory for a preliminary screening visit as described previously 
in detail [15], before returning to establish peak cardio-respiratory parameters during the 
completion of an incremental-maximal treadmill running protocol as per the methods of 
Campbell et al [15], to determine the individual speed participants would run at during the 
experimental trial. The control group completed the same preliminary tests at the Exercise 
Physiology laboratory at Northumbria University. 
Experimental design 
Type 1 diabetes patients were fitted with a real-time continuous glucose monitor (Paradigm 
Veo, Medtronic diabetes, Northridge, CA, USA) >24 h prior to the laboratory visit with high 
and low alerts set to help maintain glycaemia within normal ranges prior to the experimental 
session. Participants did not exercise within 96 h of the experimental visit. 
On the experimental day participants were provided with standardised cereal-based breakfast 
and pasta-based lunch; prescribed by the research team. Participants arrived to the laboratory 
at 17:00 h. Following a resting blood sample participants consumed a pre-exercise 
carbohydrate bolus (corn flakes, peaches, semi-skimmed milk; 1738 ± 71 kJ / 415 ± 17 kcal) 
equating to 1.0 g.carbohydrate.kg
-1
 body mass. With this meal, patients self-administered a 
25 % (2.0 ± 0.5 IU) dose (i.e. a 75 % reduction [15–19]) of rapid-acting insulin into the 
abdomen. Following this bolus, participants remained rested for 60 min, before commencing 
45 min of treadmill running at a speed calculated to elicit 70 % of VO2max. This exercise 
intensity falls within current recommendations of the American College of Sports Medicine 
[20]. All participants completed the exercise protocol and there were no hypoglycemic 
episodes within the Type 1 diabetes group. 
After exercise, participants remained at rest for 60 min before a further blood sample was 
collected. Participants were then discharged from the laboratory. On the following morning, 
participants returned to the laboratory at 08:00 h for a further resting, fasted blood sample. 
Blood sampling and data analysis 
Venepuncture technique was used to collect 10 ml of whole blood at each respective sample 
point. After discarding the first four ml of collected blood, samples were evenly dispersed 
into a K2EDTA and lithium heparin tube. The lithium heparin tube was centrifuged for 15 
min at 3000 rpm (4 °C) and stored at -80 °C for retrospective analysis of plasma Human 
TNF-α (Quantikine ELISA, R&D Systems, Roche Diagnostics, West Sussex, UK). The 
K2EDTA was sent for analysis of cEPCs and cECs immediately and was processed within 2 
h [21]. 
Circulating endothelial progenitor cells and circulating endothelial cells 
Flow cytometry 
100 μl of whole blood was incubated with 5 μl of V500 CD45 (BD Biosciences, Oxford, 
UK), 20 μl of PerCP-Cy5.5 CD34 (BD Biosciences, Oxford, UK), 5 μl of PE VEGFR-2+ 
(R&D Systems, Roche Diagnostics, West Sussex, UK), 5 μl APC CD133 (BD Biosciences, 
Oxford, UK), 10 μl FITC CD144 (BD Biosciences, Oxford, UK) for 30 min. Subsequently, 2 
ml of pharmlyse (BD Biosciences, Oxford, UK) was used to lyse the red cells. The sample 
was then analysed by flow cytometry on BD FACS Canto™ II system and samples were run 
to approximately 500,000 total events. Analysis was carried out using BD FACSDiva™ 
software. On average 440,000 events were counted. CEPCs events were defined using the 
most recent definition of CD45
dim
CD34
+
 VEGFR2 (KDR)
+
, as recommended by Van 
Craenenbroeck et al. [21]. Intra-assay variation (CD45
dim
CD34
+
VEGFR-2
+
) was less than 8 
%. The results were expressed as % leukocytes [22, 21]. CECs events were defined as 
CD45
dim
CD133
-
CD34
+
CD144
+
 [23, 24]. 
Statistical analysis 
Statistical analysis was performed using PASW Statistics 18 software (IBM, Armonk, NY) 
with significance set at p ≤ 0.05. Plasma TNF-α responses were analysed using mixed model 
ANOVA (group*time) and are presented as mean ± SEM. CEPCs and CECs responses were 
assessed using two-way Friedman’s analysis and are presented as median ± IQR. Between 
group differences, and comparisons of the delta-change in cEPCs and cECs counts, were 
assessed using Mann-Whitney U test. Relationships were assessed with Pearsons product 
moment correlation coefficient or Spearman’s rank order correlation coefficient. 
Results 
TNF-α 
Plasma TNF-α responses are presented in Fig. 1. There was no group*time interaction (P = 
0.324), or change over time (P = 0.103), however there was a significant effect of group (P < 
0.001). The Type 1 diabetes group elicited ~4 fold greater TNF-α concentrations at all sample 
points, when compared to control (Fig. 1). 
Fig. 1 Plasma TNF-α at rest, 60 min post-exercise, and on the morning after exercise. Solid 
black bars = Control group, solid white bars = Type 1 diabetes group. * indicates a significant 
between group difference (P < 0.05). Data presented as mean ± SEM 
CEPCs & cECs 
CEPCs counts are presented in Fig. 2a. Baseline cEPCs counts were similar between groups 
(Fig. 2a). There was a significant increase in cEPCs counts after exercise within the control 
group (P = 0.016), however, there was no change within the Type 1 diabetes patients (P = 
0.202). CEPCs counts peaked the morning after exercise within the control group (Fig. 2a) 
and the delta change, from baseline to morning, tended to be greater within the control group 
(Fig. 2b; P = 0.09). The median cEPCs count increased by 139 % and 27 % in the control and 
type 1 diabetes groups, respectively (P = 0.01). CECs count responses are presented in Fig. 3. 
CECs count was similar at all-time points between groups, and there was no significant 
change in cECs with exercise within either Type 1 diabetes (P = 0.179) or control (P = 0.236) 
groups. 
Fig. 2 a Circulating endothelial progenitor cell (cEPC) counts at rest, 60 min post-exercise, 
and on the morning after exercise. Solid black bars = Control group, solid white bars = Type 
1 diabetes group. ≠ indicates within conditions difference to pre-exercise, # indicates within 
condition difference to post-exercise (P < 0.05). b Change in cEPCs counts from rest to the 
morning after exercise. Solid black bars = Control group, solid white bars = Type 1 diabetes 
group. Data presented as median ± IQR 
Fig. 3 Circulating endothelial cell (cECs) counts at rest, 60 min post-exercise, and on the 
morning after exercise. Data presented as median ± IQR 
Relationships between variables 
Within the Type 1 diabetes group, the delta change in cEPCS from rest to the following 
morning was related to HbA1c (r = -0.65, P = 0.021) and TNF-α (r = -0.766, P = 0.005). 
There were no other significant relationships between cEPCs, cECs and TNF-α and 
participant characteristics (VO2peak, BMI, age and duration of diabetes) in either the control or 
Type 1 diabetes group. 
Discussion 
This study aimed to examine cEPCs, cECs and TNF-α at rest, and in response to acute 
submaximal exercise, in physically fit males with and without Type 1 diabetes. This study is 
the first of this kind and we have shown that resting cEPCs and cECs were similar between 
groups, despite patients demonstrating ~4 fold greater TNF-α concentrations. However, the 
increase in cEPCs was blunted in the patients, with the change from rest to the morning 
following exercise being ~112 % lower in Type 1 diabetes, when compared to control 
participants. Furthermore, our data showed that this blunted response within the Type 1 
diabetes group appeared to be predicted by HbA1c and TNF-α concentrations. 
Resting cEPCs and cECs 
Our finding that resting cEPCs and cECs were similar between groups is in agreement with 
Fadini et al. [25], but also contrasts with other literature in the area [4, 3]. In comparison with 
Sibal et al. [4], the Type 1 diabetes patients of this study were of comparable age and had 
similar duration of diabetes and also shared a raised inflammatory state. The difference in the 
findings are potentially explained by the high cardio-respiratory fitness and excellent 
glycemic control of our patients (HbA1c ~7 %, 53 mmol/mol vs. ~8.5 %, 69.4 mmol/mol 
[4]). Indeed, the participants in the study of Fadini et al. [25] also had good HbA1c (~7.7 %). 
Whilst the relationship between glycemic control and cEPCs is established in Type 2 diabetes 
and acute myocardial infarction [26, 27], there are few studies in Type 1 diabetes. Most 
recently it has been shown that in children with Type 1 diabetes, cEPCs count was inversely 
related with HbA1c [28]. In our study, it should be reassuring to both patients and clinicians 
that after achieving good glycemic control cEPCs were comparable to healthy controls. 
However, since our patients were also very fit, it would be interesting to investigate the 
change in HbA1c and cardio-respiratory fitness both independently, and concomitantly (e.g. 
via an exercise training programme), to provide further insight into the normalised cEPCs we 
show. 
cEPCs response to exercise 
This is the first study to examine acute exercise and cEPCs regulation in Type 1 diabetes and 
our findings suggest that regulation of cEPCs release in response to an exercise stimulus may 
be abnormal despite eliciting normal resting cEPCs and excellent glycemic control. Research 
examining the bone marrow biology of both animals and patients with diabetes confirms that 
bone marrow function is impaired [29] which may reduce cEPCs mobilisation [25]. Recent 
research has shown that the mobilisation of cEPCs in response to administration of 
recombinant granulocyte colony-stimulating factor is impaired in diabetes patients [25]. 
Speculatively, bone marrow function may also have contributed to the blunted cEPCs 
response to exercise demonstrated in the Type 1 diabetes patients. 
It is well established that resting cEPCs are normal or high in active individuals [13, 9], thus 
it is of interest that both groups of participants in our current study had a cardio-respiratory 
fitness (VO2max 50 ml.kg.min
-1
) which would categorise them as excellent, or above average 
(average VO2max for males aged ~27 being ~ 42 ml.kg.min
-1
 [20]). Earlier research has 
described ~4 fold higher cEPCs in trained marathon runners when compared to sedentary 
control participants [13], and there is evidence that regular aerobic-exercise training is an 
effective intervention to raise cEPCs in both healthy [13] and patient populations [9, 30]. 
Potentially, the regular aerobic exercise engaged in by the participants in this study, 
evidenced by high cardio-respiratory fitness, may additionally explain the comparable resting 
cEPCs shown. 
Inflammation and cEPCs 
Our study provides another interesting finding that the comparable cEPCs and cECs between 
groups were concomitant with ~4 fold higher TNF-α concentrations seen in our Type 1 
diabetes patients. The raised inflammation is in agreement with our previous data of Sibal et 
al. [4]. There is evidence, in advanced cardiovascular disease patients, that cEPCs are 
reduced potentially due to the myelosuppressive effects of TNF-α [31]. Furthermore, three 
months of TNF-α inhibitory drug treatment has been shown to significantly raise cEPCs in 
rheumatoid arthritis patients [32]. Further research is required to investigate the interaction 
between the anti-inflammatory effects of regular exercise in populations which experience 
chronic inflammation, such as Type 1 diabetes. 
We show for the first time that despite the excellent glycemic control and high physical 
fitness of the Type 1 diabetes patients there was a blunting of the rise in cEPCs elicited after 
exercise. Shear stress, increased nitric oxide (NO) production, through increased activity of 
endothelial nitric oxide synthase, and hypoxia are suggested to be key stimuli that contribute 
to the mobilisation of cEPCs with exercise [33, 9]. However, in some instances oxidative 
stress can reduce NO availability, which could, speculatively, attenuate the signal for cEPCs 
mobilisation. Recent research has shown that well controlled Type 1 diabetes patients 
demonstrate increased oxidative stress during aerobic exercise, in comparison with non-
diabetic control participants [34]. Furthermore, there may also be a role for the 
myelosuppressive effect of TNF-α in these responses. Future research should examine the 
role of both oxidative stress and inflammatory signalling in the acute cEPCs response to 
exercise. 
Although this study is limited by a relatively small sample size, it is important to consider the 
homogenous group that were observed, with patients all male, aged 19–34 years, HbA1c range 
of 6–7.9 %, and all physically fit; as such, the importance of these data should not be 
underestimated. Future research should explore how improving HbA1c independently of 
improving physical fitness influences markers of vascular repair at rest and in response to 
exercise. Conversely, it would be of interest to explore if improving physical fitness can 
rescue the deleterious effect of poor glycaemic control on cEPCs regulation. Furthermore, the 
role of the insulin species patients are treated with could be an additional factor to consider 
when examining the impact of exercise on cEPCs in this population [35]. 
Conclusions 
In conclusion, Type 1 diabetes patients with high cardio-respiratory fitness and excellent 
glycemic control present normal resting markers of vascular repair (cEPC’s) and injury 
(cECs), despite being in a persistent inflammatory state (raised TNF-α). However, the cEPCs 
response to acute exercise appears blunted, potentially limiting the cardiovascular benefits of 
exercise. 
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